Elutia Inc (ELUT)
2.80
+0.03
(+1.08%)
USD |
NASDAQ |
May 01, 15:55
Elutia Enterprise Value: 71.85M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 71.85M |
| April 29, 2024 | 75.75M |
| April 26, 2024 | 72.09M |
| April 25, 2024 | 74.77M |
| April 24, 2024 | 74.77M |
| April 23, 2024 | 74.19M |
| April 22, 2024 | 75.50M |
| April 19, 2024 | 75.26M |
| April 18, 2024 | 78.67M |
| April 17, 2024 | 78.42M |
| April 16, 2024 | 74.15M |
| April 15, 2024 | 75.38M |
| April 12, 2024 | 77.21M |
| April 11, 2024 | 78.42M |
| April 10, 2024 | 73.82M |
| April 09, 2024 | 73.94M |
| April 08, 2024 | 77.86M |
| April 05, 2024 | 76.49M |
| April 04, 2024 | 79.41M |
| April 03, 2024 | 81.10M |
| April 02, 2024 | 79.16M |
| April 01, 2024 | 79.65M |
| March 28, 2024 | 80.86M |
| March 27, 2024 | 80.86M |
| March 26, 2024 | 82.68M |
| Date | Value |
|---|---|
| March 25, 2024 | 83.78M |
| March 22, 2024 | 84.26M |
| March 21, 2024 | 82.08M |
| March 20, 2024 | 84.75M |
| March 19, 2024 | 86.69M |
| March 18, 2024 | 86.69M |
| March 15, 2024 | 84.50M |
| March 14, 2024 | 83.53M |
| March 13, 2024 | 76.98M |
| March 12, 2024 | 72.85M |
| March 11, 2024 | 82.32M |
| March 08, 2024 | 83.05M |
| March 07, 2024 | 91.54M |
| March 06, 2024 | 90.09M |
| March 05, 2024 | 91.79M |
| March 04, 2024 | 93.48M |
| March 01, 2024 | 89.84M |
| February 29, 2024 | 92.47M |
| February 28, 2024 | 87.51M |
| February 27, 2024 | 84.49M |
| February 26, 2024 | 84.00M |
| February 23, 2024 | 80.61M |
| February 22, 2024 | 85.69M |
| February 21, 2024 | 93.92M |
| February 20, 2024 | 85.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
26.54M
Minimum
Mar 22 2023
179.96M
Maximum
Dec 03 2020
86.15M
Average
81.32M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 978.51M |
| Retractable Technologies Inc | -13.49M |
| Xtant Medical Holdings Inc | 132.57M |
| Asensus Surgical Inc | 46.00M |
| Catheter Precision Inc | 0.776M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.314M |
| Revenue (Quarterly) | 5.875M |
| Total Expenses (Quarterly) | 11.67M |
| EPS Diluted (Quarterly) | -0.35 |
| Gross Profit Margin (Quarterly) | 36.19% |
| Profit Margin (Quarterly) | -158.5% |
| Earnings Yield | -73.57% |
| Normalized Earnings Yield | -66.71 |